申请人:Roswell Park Cancer Institute
公开号:US20140194477A1
公开(公告)日:2014-07-10
The invention relates to phosphorylation inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating cell proliferative disorders, especially cancer.